Is Papa John's Enhanced Loyalty Program Strengthening Repeat Business? — Positive

PZZA   Zacks Investment Research — August 18, 2025

PZZA's loyalty revamp is boosting repeat orders, adding 2.7 million new members and fueling stronger customer engagement.

image for news Is Papa John's Enhanced Loyalty Program Strengthening Repeat Business?

Schwab Witnesses Rise in July 2025 Client Assets: What's Behind it? — Positive

SCHW   Zacks Investment Research — August 18, 2025

SCHW's client assets hit $10.96 trillion in July 2025, fueled by market gains and rising client engagement.

image for news Schwab Witnesses Rise in July 2025 Client Assets: What's Behind it?

Jay McCanless, Wedbush housing analyst, joins CNBC's 'Squawk on the Street' to discuss outlooks on homebuilder sentiment, expectations for the housing market, and much more.

image for news Wedbush's Jay McCanless: Berkshire's bullishness on DR Horton and Lennar shows promise for housing

Sitio Royalties Corp. Stockholders Approve Merger with Viper Energy, Inc. — Neutral

STR   Business Wire — August 18, 2025

DENVER--(BUSINESS WIRE)--Sitio Royalties Corp. (NYSE:STR) (“Sitio” or the “Company”) today announced that, at a special meeting of Sitio stockholders held today, the stockholders of the Company approved the previously announced merger (the “Merger”) between Sitio and Viper Energy, Inc. (“Viper”). The Merger is anticipated to close on August 19, 2025. As previously announced, Sitio stockholders are entitled to receive 0.4855 shares of Class A common stock of New Cobra Pubco, Inc. (“New Viper”) f.

image for news Sitio Royalties Corp. Stockholders Approve Merger with Viper Energy, Inc.

Novo Nordisk's Wegovy receives FDA approval to treat serious liver disease — Positive

NVO   CNBC Television — August 18, 2025

CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on Novo Nordisk, what new FDA approval on its Wegovy drug means for sales, and much more.

image for news Novo Nordisk's Wegovy receives FDA approval to treat serious liver disease

Recent media reports, originating from an AI-generated article on The Motley Fool and widely syndicated, misstated Roadzen's analyst expectations as over $21 million in Q1 revenue, implying a revenue miss of more than 50%. Roadzen clarifies that these figures were never issued by its covering analysts, and that its record first quarter — the strongest Q1 in Company history — was in line with its operating plan and market estimates. Recent media reports, originating from an AI-generated article on The Motley Fool and widely syndicated, misstated Roadzen's analyst expectations as over $21 million in Q1 revenue, implying a revenue miss …

image for news Roadzen Addresses Inaccurate Reporting of Analyst Expectations in Q1 FY2026 Results

HF Foods: Weathering Tariffs And Slowing Asian Restaurant Traffic — Neutral

HFFG   Seeking Alpha — August 18, 2025

HF Foods faces major headwinds: persistent tariffs on Chinese imports and declining Asian restaurant traffic, both pressuring margins and growth. Despite record Q2 revenue and improved margins, much of the recent strength was driven by one-off factors like pre-tariff buying and price hikes. Cash flow is stable, but high leverage and ongoing Capex limit flexibility for major acquisitions or aggressive growth without further debt.

image for news HF Foods: Weathering Tariffs And Slowing Asian Restaurant Traffic

Gold price stalls below 50-day MA as traders await Powell's Jackson Hole speech and Fed rate cut signals. Technical weakness keeps outlook neutral to bearish.

image for news Gold News: 50-Day Moving Average Caps Gains, Eyes on Powell at Jackson Hole and Inflation

Novo Nordisk expands access to Ozempic, Wegovy through GoodRx and other platforms — Positive

GDRX  NVO   Proactive Investors — August 18, 2025

Novo Nordisk (NYSE:NVO) shares moved higher on Monday after it was announced that US patients can access its diabetes drug Ozempic at a cheaper price through several platforms, expanding access to the therapy for those who do not have insurance coverage. Patients can pay $499 in cash per month through the drug's website, Novo Nordisk's patient assistance program, the company's direct-to-consumer online pharmacy and via drug savings platform GoodRx.

image for news Novo Nordisk expands access to Ozempic, Wegovy through GoodRx and other platforms

Should You Buy Sterling Stock After Its Solid Q2 Earnings Beat? — Positive

STRL   Zacks Investment Research — August 18, 2025

STRL's solid Q2 earnings beat, driven by data center demand and backlog growth, puts the stock in the spotlight.

image for news Should You Buy Sterling Stock After Its Solid Q2 Earnings Beat?

2 Phenomenal Dividend Growth Stocks That Insiders Are Buying Hand Over Fist — Positive

EPD  LLY   24/7 Wall Street — August 18, 2025

Key Points in This Article: Dividend growth investing offers stable income and capital appreciation through compounding returns.

image for news 2 Phenomenal Dividend Growth Stocks That Insiders Are Buying Hand Over Fist

Brazil's Petrobras eyes increase of production at three FPSOs — Positive

PBR  PBR-A   Reuters — August 18, 2025

Brazilian state-run oil firm Petrobras is looking to increase production at three floating offshore production platforms (FPSO) it operates in the country, the head of Exploration and Production, Sylvia dos Anjos, said on Monday.

image for news Brazil's Petrobras eyes increase of production at three FPSOs

CrowdStrike Holdings (NASDAQ: CRWD) is trading at $424.90 as of midday Monday, changing little from the previous close.

image for news Wall Street updates Crowdstrike (CRWD) stock price ahead of earnings

ULTY's Big Payouts Come With a Big Trade-Off — Positive

ULTY   24/7 Wall Street — August 18, 2025

At first glance, the YieldMax Ultra Option Income Strategy ETF (NYSEARCA:ULTY) might look like the ultimate cash machine that could nearly double your money.

image for news ULTY's Big Payouts Come With a Big Trade-Off

Nvidia NVDA is set to beat Wall Street's expectations once again, driven by surging demand for AI and its new Blackwell architecture.

image for news Nvidia's AI Expansion Could Push Revenue To $300 Billion By 2026, Analyst Says

Wall Street Newbie Climbs on Bullish Analyst Coverage — Positive

MH   Schaeffers Research — August 18, 2025

Education stock McGraw Hill Inc (NYSE:MH) is surging, last seen up 6.4% to trade at $14.20, after today's wave of bull notes.

image for news Wall Street Newbie Climbs on Bullish Analyst Coverage

Sezzle Stock Skyrockets 324% in a Year: Is it the Right Time to Buy? — Positive

SEZL   Zacks Investment Research — August 18, 2025

SEZL posts soaring revenues, record GMV and standout profitability with its On-Demand product strategy.

image for news Sezzle Stock Skyrockets 324% in a Year: Is it the Right Time to Buy?

Nvidia's China Export: Buy The Rumor And Sell The News (Rating Downgrade) — Neutral

NVDA   Seeking Alpha — August 18, 2025

Recent developments surrounding Nvidia Corporation's China export license reminds of the wisdom to buy the rumor and sell the news. Nvidia's China export catalyst is now fully priced in for several reasons. And I am afraid the benefits of renewed exports won't be as large as expected for several reasons.

image for news Nvidia's China Export: Buy The Rumor And Sell The News (Rating Downgrade)

AT&T: Income Cleans Up — Positive

T   Seeking Alpha — August 18, 2025

AT&T's earnings are finally aligning with its streamlined business after years of divestitures. The recent Lumen acquisition is a focused, synergistic move. Ongoing results from core businesses now dominate.

image for news AT&T: Income Cleans Up

Mission Produce vs. Limoneira: Who Holds the Reins in Fresh Produce? — Positive

AVO  LMNR   Zacks Investment Research — August 18, 2025

AVO's avocado dominance contrasts with LMNR's citrus-led diversification, raising the question of which fresh produce model drives stronger growth.

image for news Mission Produce vs. Limoneira: Who Holds the Reins in Fresh Produce?